Insider Transactions in Q2 2023 at Taysha Gene Therapies, Inc. (TSHA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
18,100
-0.2%
|
$0
$0.7 P/Share
|
|
Jun 22
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
10,508
-0.12%
|
$0
$0.7 P/Share
|
|
Jun 21
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
138,962
-1.52%
|
$0
$0.7 P/Share
|
|
Jun 20
2023
|
R.A. Session Ii |
SELL
Open market or private sale
|
Direct |
295,653
-3.14%
|
$0
$0.71 P/Share
|
|
May 31
2023
|
Kamran Alam CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,230
+2.1%
|
-
|
|
May 16
2023
|
Sukumar Nagendran President and Head of R&D |
BUY
Open market or private purchase
|
Direct |
5,000
+12.75%
|
$0
$0.68 P/Share
|